Preview

Strategic Alliance in Indian Pharmaceutical Industry

Better Essays
Open Document
Open Document
8549 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Strategic Alliance in Indian Pharmaceutical Industry
Sri Sharada Institute Of Indian Management - Research
(A unit of Sri Sringeri Sharada Peetham, Sringeri)
Approved by AICTE
Plot No. 7, Phase-II, Institutional Area, Behind the Grand Hotel, Vasant Kunj,
New Delhi – 110070
Tel.: 2612409090 / 91; Fax: 26124092
E-mail: administration@srisim.org; Website: www.srisim.org

DEVELOPMENT DAY PROJECT REPORT

STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY

Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. |

MANAGING THROUGH WISDOM

INTRODUCTION

The competitive landscape of the Indian business firm has seen a dynamic change in the 1990s as a result of dual institutional changes of economic liberalization and changing intellectual policy regimes. Liberalization and its accompanying changes in trade, industry, foreign investment and technology policy regime, triggered previously protected Indian companies towards capability enhancement. This translated into a two pronged competitive strategy by the Indian firm - the adoption of a defensive strategy was aimed at protecting its competitive position in the domestic market and an assertive strategy aimed at leveraging new opportunities through internationalization. This paper examines the changing strategic orientations of the Indian Pharmaceutical industry through a study of its international venturing. It finds that firms have used acquisition as well as alliances in the spirit of co-opetition rather than competition, both in the domestic and international market as an important element of the industry’s survival strategy.

Introduction to Indian Pharmaceutical Industry

In the The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and

You May Also Find These Documents Helpful

  • Good Essays

    The faculty of Pharmaceutical Sciences in BUK was established in the year 2016. As a new faculty, the need for professionals in the field of Pharmaceutical Science increased and we were notified by some of the lecturers that there is need for professionals in the field, Hence my interest in Pharmaceutical Science.…

    • 1932 Words
    • 8 Pages
    Good Essays
  • Good Essays

    Quick Dissolving Chips

    • 341 Words
    • 2 Pages

    latest decade, and the field has transformed into a quick creating zone in the pharmaceutical…

    • 341 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Eli Lily Case Study

    • 489 Words
    • 2 Pages

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    2- Instead of outsourcing the manufacturing of parts, Silvio can build a new plant from the ground up to build the elevators locally.…

    • 805 Words
    • 4 Pages
    Good Essays
  • Good Essays

    PESTLE Analysis of the Pharmaceutical Industry Political - Recent US health reforms has led to increased pressure on price. - Increased push for continued overseas aid, particularly through the United Nations and the European Union, with price of the drugs being a major factor in the supplier choice. Economical - Due to the current economic climate, price has become a major factor in pharmaceuticals especially on drugs where generic brands are also available. Social - Skilled employees can be difficult to source in other third world countries where segments of the batch production line may be based. - Increasing pressure on pharmaceutical industry to support developing countries through the supply of reduced cost drugs, tightening margins. Technological - Technology evolution in the industry is fast and needs to be updated frequently to avoid being left behind with the first to implement radical new technology into the production process gaining 'first mover' advantages Legal - Many legal restraints to releasing drugs suitable for human consumption - High legal costs associated with passing drugs for human consumption and dealing with unforeseen side effects of a drug Environmental - Batch production processes of pharmaceutical products can have manufacturing plants based in multiple countries. The carbon footprint of many drugs can be very large due to the amount of transport involved in the batch production processes.…

    • 3196 Words
    • 13 Pages
    Good Essays
  • Better Essays

    is a member of the Economics and Strategy Group at Aston University, where he currently teaches Value Based Strategy and Entrepreneurial Strategy to final year and postgraduate students. Graham joined ICI Agrochemicals Research, before entering the pharmaceutical industry, where he worked in marketing and general management roles for several top ten pharmaceutical companies. His most recent role was Strategic Planning Director for Astra Pharmaceuticals, where he was responsible for strategy development, which enabled him to gain first hand experience within the world’s key pharmaceutical markets. His primary research interests include competitive strategy, merger, acquisition and the alignment of strategy to shareholder value creation.…

    • 5439 Words
    • 22 Pages
    Better Essays
  • Powerful Essays

    Economic: Globalization of the pharmaceutical industry is an exciting opportunity to have research and development done at cheaper prices in other countries. However, this could be a double edged sword for companies because it is easy for other countries, such as India, to produce generic versions of the drug in bulk.…

    • 1345 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    There's a time for everything. For Dr Ramakanta Panda, it was time to build a 'modern hospital' in India. As a cardiac surgeon from the prestigious Cleveland Clinic, US, he was known for his super-safe hands. But his ideas proved too radical for the design team. Whoever heard of picture windows to ward off ICU psychosis? Or counselling areas for patients' relatives? How would cafeteria, convenience store, library, public booth, Internet access, and hotel-like front desk create a "healing experience"? As modernity clashed with convention, Panda whisked the team off to the US to show at first hand what modern hospitals look like. Awed by his passion and armed with 5,000 photographs, they returned to translate his dream into concrete: the Asian Heart Institute (AHI) in Mumbai. Seven years later, Panda, known today as "the prime minister's surgeon", is busy planning yet another AHI. "A modern hospital focuses entirely on patient satisfaction," he says. "India didn't have that culture then. But it's quite standard now," he smiles. Indeed it is.…

    • 2076 Words
    • 9 Pages
    Powerful Essays
  • Powerful Essays

    Ranbaxy Daiichi

    • 1235 Words
    • 5 Pages

    • Present size of $14 billion. • Ranks 4th in world in terms of production and 13th in terms of consumption. • Highly fragmented. 325 large and medium-scale companies and 26000 small-scale companies. • Can be divided in 2 segments – Formulation and Bulk Drugs Market Share of segments…

    • 1235 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    Pharmaceutical is the core of Bangladesh’s Healthcare sector, and serves as one of the most important manufacturing industry. With a history since 1950s, the industry has now turned one of the most successful pharmaceuticals manufacturing industry among the developing countries. Presently, the industry meets 97% of local demand and exports to more than 80 countries.…

    • 1573 Words
    • 7 Pages
    Powerful Essays
  • Best Essays

    The past two decades has been an era of global evolution, in which the globalisation of markets, the convergence of and rapid shifts in technologies, and the breakdown of many traditional industry boundaries, has rendered strategic alliances a competitive necessity (Ohmae, 1989). A single firm is unlikely to possess all the resources and capabilities to achieve global competitiveness. Therefore, collaboration among organisations that possess complementary resources is often necessary for survival and growth (Dussauge, Garrette and Mitchell, 1998). Defined as a long-term, explicit contractual agreement pertaining to an exchange or combination of some of a firm's resources with another firm(s), strategic alliances allow firms to share risks and resources, gain knowledge and technology, expand the existing product base, and obtain access to new markets (Burgers, Hill and Kim, 1993; Dacin, Hitt and Levitas, 1997; Hagedoorn and Schakenraad, 1993; Morosini, 1999). Not surprisingly then, strategic alliances have become an increasingly popular strategy, particularly for entry into international markets (Osborn and Hagedoorn, 1997; Cullen, 1999). Approximately 20,000 alliances were formed worldwide between 1996 and 1998 (Harbison and Pekar, 1998; cited in The Economist, May 15, 1999), and it has been estimated that the number of strategic alliances will continue to increase at an annual rate of 25 per cent (Day, 1994). However, despite the frequency with which today's alliances are occurring, there is overwhelming evidence to suggest that alliances fail to deliver anywhere near the promised payoffs. The percentage of alliances that are failures runs the gamut across the research from a low 30 per cent (Cullen, 1999), to a high 70 per cent (Dacin et al, 1997). Apart from the inherent risk of entering into an alliance, partner compatibility is often cited as the main reason for alliance failure (Dacin et al,…

    • 3996 Words
    • 16 Pages
    Best Essays
  • Good Essays

    Going Global: Indian Mncs

    • 1638 Words
    • 7 Pages

    Till a few years back, the term MNC in India meant an organization with its headquarters located outside India and having presence in India as a part of its global network. In other words, in Indian eyes,”MNC” meant a foreign company, which has come into India.…

    • 1638 Words
    • 7 Pages
    Good Essays
  • Better Essays

    2. Patil JS, Kulkarni RV, Marapur SC, Dalavi VV. Introducing Pharm.D. Programme in India: A Need of the Day. Indian J. of Pharm. Pract. 2(3), Jul-Sep, 2009. Available from: http://www.ijopp.org/pdf/ijopp_vol_2_3_Jul-Sep2009.pdf#page=13 (Accessed on-September 5, 2012)…

    • 718 Words
    • 3 Pages
    Better Essays
  • Best Essays

    The Pharmaceutical sector in an especially interesting one since it is basically one of the most rapid augmenting industries being worth several trillion dollars worldwide and influencing the health of more than 4.6 billion humans worldwide. It constitutes on average over more than 10% of the GDP of the most developed nations and therefore forms a large portion of not only these countries’ economies but also the entire world economy. (Sheth, 2010)…

    • 3475 Words
    • 14 Pages
    Best Essays
  • Powerful Essays

    Foreign Trade Policy

    • 3394 Words
    • 14 Pages

    Question 3. What are the steps taken by the Government of India to promote export of Pharmaceutical products from India. Highlight the problems faced by the Indian Pharmaceutical companies in venturing the Foreign Market.…

    • 3394 Words
    • 14 Pages
    Powerful Essays